In the realm of molecular psychiatry, few figures have shaped the landscape as profoundly as Professor Barbara Franke. Her journey from a curious child enthralled by the wonders of nature to a pioneering researcher unraveling the molecular underpinnings of neurodevelopmental disorders exemplifies the transformative power of interdisciplinary science. Based at Radboud University Medical Center and the Donders Institute in the Netherlands, Franke’s work has been instrumental in deciphering how genetic variations translate into altered behaviors, particularly in conditions such as Attention Deficit Hyperactivity Disorder (ADHD).
Professor Franke’s scientific trajectory took a defining turn during a laboratory practical where she isolated DNA from HeLa cells — a moment she recalls with fondness as her “love affair” with molecular genetics began. Shifting her focus from primatology and the study of great apes in the wild to the complex genetic architecture of human brain disorders, Franke embarked on a mission to decode the biological pathways that govern behavior. This pivot marked the start of what would become a distinguished career addressing some of psychiatry’s most elusive questions.
With a publication record exceeding 500 peer-reviewed articles, Professor Franke ranks among the global elite of highly cited scientists. Her research goes beyond mere gene mapping; it employs integrative approaches combining genomics, bioinformatics, and experimental biology, spanning model systems from Drosophila melanogaster to human induced pluripotent stem cells. This multidisciplinary strategy allows her to explore how subtle genetic differences manifest as behavioral phenotypes, offering critical insights into neurodevelopmental conditions’ etiology.
Franke’s prominent role in founding consortia such as the International Multicentre persistent ADHD
